skip to main content

Gene expression of baseline biopsies from etrolizumab-treated ulcerative colitis (UC) patients

Identifiers: SRA: SRP063496
BioProject: PRJNA295143
GEO: GSE72819
Study Type: 
Transcriptome Analysis
Abstract: RNA sequencing was performed on RNA isolated from baseline biopsies from UC patients enrolled in the Phase II EUCALYPTUS study of etrolizumab. Gene expression differences were identified in a subset of anti-TNF naïve patients that achieved clinical remission at 10 weeks in response to etrolizumab. Overall design: Baseline colonic biopsies from UC patients treated with etrolizumab were sequenced by the Illumina HiSeq 2000 Sequencing System.
Center Project: GSE72819
External Link: /pubmed:26522261

Related SRA data

Experiments:
73 ( 73 samples )
Runs:
73 (172.8Gbp; 105.8Gb)